revealed that invasive fronts of ductal carcinoma in situ (DCIS) BC were characterized by disrupted myoepithelial layers, and low KRT14 expression which were also positive for progesterone receptor (37); Janesick et al. The gene discussed is KRT14; the disease is ductal breast carcinoma in situ.